Evidence map›Paper›PMID 30180927›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018

Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016.

Christoph Niederhauser, Nadja Widmer, Magdalena Hotz, Caroline Tinguely, Stefano Fontana, Gabrielle Allemann, Mauro Borri, Laura Infanti, Amira Sarraj, Jörg Sigle and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Prevalence and risk factors for hepatitis E virus infection in blood donors: a nationwide survey in Italy, 2017 to 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  16. Article
  17. Risk assessment of hepatitis E transmission through tissue allografts.World journal of gastrointestinal pathophysiology · 2022
    Review
  18. Transfusion-transmitted hepatitis E: What we know so far?World journal of gastroenterology · 2022
    Review
  19. Article
  20. Screening of Swiss Pig Herds for Hepatitis E Virus: A Pilot Study.Animals : an open access journal from MDPI · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Christoph NiederhauserInterregional Blood Transfusion SRC, Berne Switzerland.
Nadja WidmerInterregional Blood Transfusion SRC, Berne Switzerland.
Magdalena HotzInterregional Blood Transfusion SRC, Berne Switzerland.
Caroline TinguelyInterregional Blood Transfusion SRC, Berne Switzerland.
Stefano FontanaInterregional Blood Transfusion SRC, Berne Switzerland.
Gabrielle AllemannBlood Transfusion Service SRC, Fribourg, Switzerland.
Mauro BorriServizio Trasfusionale CRS della Svizzera Italiana, Lugano, Switzerland.
Laura InfantiBlood Transfusion Service Beider Basel, Basel, Switzerland.
Amira SarrajBlood Transfusion Service SRC Neuchâtel/Jura, Neuchâtel, Switzerland.
Jörg SigleBlood Transfusion Service SRC, Aargau/Solothurn, Switzerland.
Michèle StalderInterregional Blood Transfusion SRC, Berne Switzerland.
Jutta ThierbachBlood Transfusion Service SRC Nordostschweiz, St. Gallen, Switzerland.
Sophie WaldvogelBlood Transfusion Service SRC, Geneva, Switzerland.
Tina WiengandBlood Transfusion Service SRC Zentralschweiz, Luzern, Switzerland.
Max ZügerBlood Transfusion Service SRC Thurgau, Münsterlingen, Switzerland.
Peter GowlandInterregional Blood Transfusion SRC, Berne Switzerland.
Swiss Red Cross · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aimHepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within developed countries vary considerably; primarily due to improved diagnostic assays. The purpose of this study was to investigate the seroprevalence of anti-HEV IgG in Swiss blood donations.

Indexed as

AdolescentAdultAgedAge DistributionBlood DonorsBlood TransfusionFemaleHepatitis AntibodiesHepatitis EHepatitis E virusHumansImmunoglobulin GMaleMiddle AgedPrevalenceRNA, ViralHepatitis AntibodiesImmunoglobulin GRNA, Viralblood donorshepatitis ESwitzerlandvirus seroprevalence

Identifiers

PMID30180927
PMCPMC6124188
OpenAlexW2888840070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.